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Letters to the Editor
Complex Roles of Endothelial
Shear Stress in Vascular
Remodeling Response
With great interest I read the review article by Chatzizisis et al. (1)
regarding endothelial shear stress (ESS), coronary atherosclerosis,
and vascular remodeling. The authors stated in the text, “Recent
observations, however, indicate that low ESS leads to excessive
expansive remodeling . . .” from their diabetic hyperlipidemic
swine model. However, in their previous human study (2), they
demonstrated that constrictive remodeling occurred more fre-
quently (44%) than expansive remodeling (22%) in subsegments
with low ESS, whereas expansive remodeling occurred more
frequently (26.3%) than constrictive remodeling (5.3%) in subseg-
ments with moderate/higher ESS. These results suggest complex
roles of ESS in the vascular remodeling response, depending on
concomitant conditions including atherosclerotic stage, in addition
to differences in biology between experimental models and clinical
studies (3,4). Further clinical studies are warranted to determine
the role of ESS in vascular remodeling in humans.
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Reply
Dr. Kaneda appropriately draws attention to the complexity of
vascular remodeling. The magnitude of low endothelial shear stress
(ESS), as well as changes in ESS and the rate of change in ESS,
all contribute to the pathobiology of atherosclerosis (1,2). In our
human pilot study, we observed expansive remodeling in areas of
initially low or high ESS. It is therefore likely that expansive
remodeling occurs through different mechanisms in different local
environments and under different flow regimes (3).
Low ESS enhances lipid accumulation and local inflammation.
The enzymatic degradation of the underlying internal elastic
lamina and media that follow ultimately lead to expansive remod-
eling (1). Whether the expansive remodeling response becomes
excessive or compensatory is likely dependent on the magnitude of
low ESS (1). Very low ESS induces an intense inflammatory
response that leads to excessive lumen and wall expansion (exces-
sive expansive remodeling) (1). These wall changes further reduce
local ESS, establishing a cascade of inflammation and excessive
expansive remodeling, which can transform a stable plaque into a
thin cap fibroatheroma. In contrast, in areas with limited reduc-
tions in ESS, local inflammation is modest, and the cellular
reaction might strengthen the plaque and lead to compensatory
expansive remodeling (1). The changes in the vessel wall and the
minimal narrowing of the lumen might restore ESS to more
physiologic levels and thereby promote plaque quiescence.
High ESS might also lead to expansive remodeling, but through
a different mechanism. Reactive dilation of the plaque-free wall
with normal flow-responsive endothelium in the area of an
eccentric plaque can normalize the local ESS environment (4).
In our human pilot study (3), we observed that areas with low
baseline ESS can develop constrictive remodeling at follow-up.
Although the pathobiologic mechanisms responsible for constric-
tive remodeling are less clear than those of expansive remodeling,
constrictive remodeling in our patients may have been related to
subclinical plaque microrupture and subsequent healing (5). Alter-
natively, a fibroproliferative smooth-muscle cell phenotype may
have been consistently operative throughout the natural history
course of that plaque.
We agree that it is critical to understand these vascular behavior
patterns in more detail because the ultimate clinical manifestations
of coronary disease depend on the morphologic evolution and flow
remodeling of the atherosclerotic plaque (1). Although clinical
studies are essential to the identification of atherosclerotic patterns,
animal models enable specific delineation of the dynamic and
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